chloroquine and rifampin

chloroquine has been researched along with rifampin in 58 studies

Research

Studies (58)

Timeframe	Studies, this research(%)	All Research%
pre-1990	5 (8.62)	18.7374
1990's	2 (3.45)	18.2507
2000's	18 (31.03)	29.6817
2010's	28 (48.28)	24.3611
2020's	5 (8.62)	2.80

Authors

Authors	Studies
Clark, AM; Dunbar, DC; Muhammad, I; Takamatsu, S; Walker, LA	1
Gochfeld, DJ; Hamann, MT	1
Gerena, L; Milhous, WK; Opsenica, D; Pocsfalvi, G; Solaja, BA; Terzić, N; Tinant, B	1
Al-Said, MS; Dunbar, DC; El Sayed, KA; Hamann, MT; Higa, T; Kelly, M; Orabi, KY	1
Hamann, MT; Mesecar, AD; Rao, KV; Santarsiero, BD; Schinazi, RF; Tekwani, BL	1
Hamann, MT; Kasanah, N; Rao, KV; Schinazi, RF; Tekwani, BL; Wahyuono, S	1
König, GM; Papendorf, O; Wright, AD	1
Alonso, D; Donia, MS; Franzblau, SG; Garcia-Palomero, E; Hamann, MT; Khan, SI; Martinez, A; Medina, M; Peng, J; Rao, KV; Tekwani, BL; Wahyuono, S; Willett, KL	1
Karmodiya, K; Mishra, S; Ramya, TN; Surolia, A; Surolia, N	1
Dahl, EL; Rosenthal, PJ	1
Lombardo, F; Obach, RS; Waters, NJ	1
Artursson, P; Bergström, CA; Hoogstraate, J; Matsson, P; Norinder, U; Pedersen, JM	1
Ahlin, G; Artursson, P; Bergström, CA; Gustavsson, L; Karlsson, J; Larsson, R; Matsson, P; Norinder, U; Pedersen, JM	1
González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M	1
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV	1
Brun, R; Franzblau, SG; Huang, Q; Kozikowski, AP; Mao, J; Wan, B; Wang, Y	1
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A	1
Choo, YM; Doerksen, RJ; Gertsch, J; Hamann, MT; Jacob, MR; Khan, SI; Kudrimoti, S; Madgula, V; Mayer, AM; Odde, S; Peng, J; Pennaka, HK; Prasanna, S; Rao, KV; Tekwani, BL; Tu, LC; Wang, B	1
Chibale, K; Franzblau, SG; Guantai, EM; Gut, J; Hans, RH; Lategan, C; Rosenthal, PJ; Smith, PJ; Wan, B	1
Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV	1
García-Mera, X; González-Díaz, H; Prado-Prado, FJ	1
Glen, RC; Lowe, R; Mitchell, JB	1
Afshari, CA; Eschenberg, M; Hamadeh, HK; Lee, PH; Lightfoot-Dunn, R; Morgan, RE; Qualls, CW; Ramachandran, B; Trauner, M; van Staden, CJ	1
Barazarte, A; Camacho, J; Charris, J; Gamboa, N; Gilman, R; Rodrigues, J; Rojas, R; Vaisberg, A	1
Chibale, K; Franzblau, SG; Gut, J; Hans, RH; Rosenthal, PJ; van Helden, PD; Wan, B; Wiid, IJ	1
Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V	1
Artursson, P; Haglund, U; Karlgren, M; Kimoto, E; Lai, Y; Norinder, U; Vildhede, A; Wisniewski, JR	1
Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY	1
Chaturvedi, V; Chauhan, K; Chauhan, PM; Puri, SK; Saxena, J; Saxena, JK; Sharma, M; Singh, SV; Srivastava, K; Trivedi, P	1
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ	1
Kalaria, PN; Raval, DK; Satasia, SP	1
Karad, SC; Purohit, VB; Raval, DK	1
Bharate, SB; Khan, IA; Khan, SI; Singh, S; Vishwakarma, RA; Yadav, RR	1
Bourguet-Kondracki, ML; Chan, ST; Copp, BR; Dalton, JP; Page, MJ; Pearce, AN; Taylor, RB; Valentin, A; Wang, J; Wiles, S	1
Franzblau, SG; Le Roch, KG; Nieves, K; Prudhomme, J; Rodríguez, AD	1
Karad, SC; Purohit, VB; Raval, DK; Thakkar, VR; Thakor, P	1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K	1
Jones, LH; Nadanaciva, S; Rana, P; Will, Y	1
Sankar, C; Umamatheswari, S	1
Baell, J; Li, J; Nagalingam, G; Nguyen, N; Schneider, EK; Triccas, JA; Velkov, T; Wilson, DW	1
Hoppe, H; Isaacs, M; Kaye, PT; Olawode, EO; Prinsloo, E; Seldon, R; Steenkamp, V; Tandlich, R; Warner, DF	1
Baartzes, N; Chibale, K; Seldon, R; Smith, GS; Stringer, T; Taylor, D; Warner, DF; Wittlin, S	1
Hoppe, HC; Isaacs, M; Kaye, PT; Krause, RWM; Manyeruke, MH; Seldon, R; Tshiwawa, T; Warner, DF	1
Adhikari, N; Gaikwad, VR; Govindarajalu, G; Karale, UB; Krishna, EV; Krishna, VS; Misra, S; Rode, HB; Sijwali, PS; Sriram, D	1
Boonlarppradab, C; Choowong, W; Kornsakulkarn, J; Saepua, S; Suriyachadkun, C; Thongpanchang, C	1
Mason, CG	1
Trautman, JR	1
Artemenko, NK; Freidlin, IS; Lyzlova, SN; Nersesova, LS; Petrova, TA	1
Benoliel, AM; Bongrand, P; Maurin, M; Raoult, D	1
Youmans, AS; Youmans, GP	1
Artemenko, NK; Freĭdlin, IS; Teĭber, EL; Voskresenskiĭ, AM	1
Charoenlarp, P; Pukrittayakamee, S; Viravan, C; White, NJ; Wilson, RJ; Yeamput, C	1
Bhat, M; Hickey, AJ	1
Abdulah, MS; Hou, LJ; Nor, NM; Raju, SS; Ravichandran, M	1
Chan, JC; Chau, CH; Chow, WS; Lam, KS; Lee, CH; Tso, AW; Yeung, CK; Yuen, MM	1
Chen, Y; Huang, K; Jing, X; Lei, M; Liang, Y; Lin, D; Liu, J; Peng, S; Tao, E; Wu, X; Xiao, S; Yang, L; Zeng, Z; Zheng, D; Zhou, T	1
Calender, A; Israel-Biet, D; Pacheco, Y; Valeyre, D	1
Amro, L; Arjdal, B; Benali, SA; Bouaré, F; Etouche, FN; Ghannane, H; Hajhouji, F; Laghmari, M; Saidi, I; Tassi, N	1

Reviews

3 review(s) available for chloroquine and rifampin

Article	Year
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans. Drug discovery today, 2016, Volume: 21, Issue:4 Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk	2016
Ocular accumulation and toxicity of certain systemically administered drugs. Journal of toxicology and environmental health, 1977, Volume: 2, Issue:5 Topics: Amitriptyline; Animals; Chloroquine; Cornea; Eye; Eye Diseases; Female; Haplorhini; Humans; Lens, Crystalline; Phenothiazines; Pregnancy; Retinal Diseases; Rifampin; Structure-Activity Relationship; Thioxanthenes; Time Factors	1977
Modeling Potential Autophagy Pathways in COVID-19 and Sarcoidosis. Trends in immunology, 2020, Volume: 41, Issue:10 Topics: Angiotensin-Converting Enzyme Inhibitors; Autophagy; Azithromycin; Betacoronavirus; Chloroquine; Coronavirus Infections; COVID-19; Host-Pathogen Interactions; Humans; Isoniazid; Lung; Pandemics; Pneumonia, Viral; Pulmonary Edema; Rifampin; Sarcoidosis; SARS-CoV-2; Severe Acute Respiratory Syndrome; Severity of Illness Index	2020

Other Studies

55 other study(ies) available for chloroquine and rifampin

Article	Year
Antimalarial, cytotoxic, and antifungal alkaloids from Duguetia hadrantha. Journal of natural products, 2001, Volume: 64, Issue:5 Topics: Alkaloids; Animals; Antifungal Agents; Antimalarials; Antineoplastic Agents, Phytogenic; Brazil; Cell Adhesion; Cell Aggregation; Humans; Magnetic Resonance Spectroscopy; Mass Spectrometry; Paraguay; Plant Extracts; Plants, Medicinal; Plasmodium falciparum; Spectrophotometry, Ultraviolet; Tumor Cells, Cultured	2001
Isolation and biological evaluation of filiformin, plakortide F, and plakortone G from the Caribbean sponge Plakortis sp. Journal of natural products, 2001, Volume: 64, Issue:11 Topics: Animals; Antimalarials; Bromobenzenes; Chromatography, High Pressure Liquid; Colonic Neoplasms; Dioxanes; Gas Chromatography-Mass Spectrometry; Hepatitis B; HIV; Humans; Jamaica; Lactones; Leukemia P388; Lung Neoplasms; Mice; Molecular Structure; Mycobacterium tuberculosis; Neoplasms, Unknown Primary; Nuclear Magnetic Resonance, Biomolecular; Plasmodium berghei; Plasmodium falciparum; Porifera; Spectrometry, Mass, Electrospray Ionization; Tumor Cells, Cultured	2001
Mixed steroidal 1,2,4,5-tetraoxanes: antimalarial and antimycobacterial activity. Journal of medicinal chemistry, 2002, Aug-01, Volume: 45, Issue:16 Topics: Animals; Anti-Bacterial Agents; Antimalarials; Chlorocebus aethiops; Crystallography, X-Ray; Inhibitory Concentration 50; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Plasmodium falciparum; Spectrometry, Mass, Electrospray Ionization; Spiro Compounds; Steroids; Structure-Activity Relationship; Vero Cells	2002
Araguspongines K and L, new bioactive bis-1-oxaquinolizidine N-oxide alkaloids from Red Sea specimens of Xestospongia exigua. Journal of natural products, 2002, Volume: 65, Issue:12 Topics: Alkaloids; Animals; Antimalarials; Antitubercular Agents; Indian Ocean; Molecular Structure; Mycobacterium tuberculosis; Nuclear Magnetic Resonance, Biomolecular; Plasmodium falciparum; Porifera; Quinolizines; Rifampin; Stereoisomerism	2002
New manzamine alkaloids with activity against infectious and tropical parasitic diseases from an Indonesian sponge. Journal of natural products, 2003, Volume: 66, Issue:6 Topics: Alkaloids; Animals; Anti-HIV Agents; Antiprotozoal Agents; Carbazoles; Carbolines; Crystallography, X-Ray; Indoles; Indonesia; Inhibitory Concentration 50; Leishmania donovani; Molecular Structure; Nuclear Magnetic Resonance, Biomolecular; Nucleosides; Porifera; Pyrroles; Stereoisomerism	2003
Three new manzamine alkaloids from a common Indonesian sponge and their activity against infectious and tropical parasitic diseases. Journal of natural products, 2004, Volume: 67, Issue:8 Topics: Alkaloids; Animals; Anti-HIV Agents; Anti-Infective Agents; Antimalarials; Antiprotozoal Agents; Carbolines; Indonesia; Microbial Sensitivity Tests; Molecular Structure; Mycobacterium tuberculosis; Nuclear Magnetic Resonance, Biomolecular; Porifera	2004
Ambigol C and 2,4-dichlorobenzoic acid, natural products produced by the terrestrial cyanobacterium Fischerella ambigua. Journal of natural products, 2005, Volume: 68, Issue:3 Topics: Animals; Antifungal Agents; Biphenyl Compounds; Carbazoles; Chlorobenzenes; Chlorobenzoates; Cyanobacteria; Microbial Sensitivity Tests; Molecular Structure; Nuclear Magnetic Resonance, Biomolecular; Phenols; Switzerland; Trypanocidal Agents; Trypanosoma brucei rhodesiense	2005
Manzamine B and E and ircinal A related alkaloids from an Indonesian Acanthostrongylophora sponge and their activity against infectious, tropical parasitic, and Alzheimer's diseases. Journal of natural products, 2006, Volume: 69, Issue:7 Topics: Alzheimer Disease; Animals; Female; Glycogen Synthase Kinase 3; HIV-1; Humans; Indole Alkaloids; Indonesia; Inhibitory Concentration 50; Leishmania donovani; Microbial Sensitivity Tests; Molecular Structure; Mycobacterium tuberculosis; Oryzias; Plasmodium falciparum; Porifera; Structure-Activity Relationship	2006
Inhibitors of nonhousekeeping functions of the apicoplast defy delayed death in Plasmodium falciparum. Antimicrobial agents and chemotherapy, 2007, Volume: 51, Issue:1 Topics: Acetone; Animals; Antimalarials; Azithromycin; Cerulenin; Chloramphenicol; Clindamycin; Erythrocytes; Fatty Acids; Gene Dosage; Humans; Organelles; Parasitic Sensitivity Tests; Plasmodium falciparum; Protozoan Proteins; Tetracycline; Thioctic Acid; Triclosan	2007
Multiple antibiotics exert delayed effects against the Plasmodium falciparum apicoplast. Antimicrobial agents and chemotherapy, 2007, Volume: 51, Issue:10 Topics: Animals; Anti-Bacterial Agents; Antimalarials; Drug Resistance; Flow Cytometry; Green Fluorescent Proteins; Plasmodium falciparum; Protein Synthesis Inhibitors; Topoisomerase II Inhibitors	2007
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds. Drug metabolism and disposition: the biological fate of chemicals, 2008, Volume: 36, Issue:7 Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding	2008
Prediction and identification of drug interactions with the human ATP-binding cassette transporter multidrug-resistance associated protein 2 (MRP2; ABCC2). Journal of medicinal chemistry, 2008, Jun-12, Volume: 51, Issue:11 Topics: Administration, Oral; Animals; Antineoplastic Agents; Antipsychotic Agents; Antiviral Agents; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Biological Transport; Cell Line; Computer Simulation; Cytochrome P-450 Enzyme System; Drug-Related Side Effects and Adverse Reactions; Estradiol; Humans; Insecta; Liver; Models, Molecular; Multidrug Resistance-Associated Protein 2; Multidrug Resistance-Associated Proteins; Neoplasm Proteins; Pharmaceutical Preparations; Pharmacology; Structure-Activity Relationship	2008
Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1. Journal of medicinal chemistry, 2008, Oct-09, Volume: 51, Issue:19 Topics: Cell Line; Computer Simulation; Drug Design; Gene Expression Profiling; Humans; Hydrogen Bonding; Liver; Molecular Weight; Organic Cation Transporter 1; Pharmaceutical Preparations; Predictive Value of Tests; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Structure-Activity Relationship	2008
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors. Journal of medicinal chemistry, 2008, Nov-13, Volume: 51, Issue:21 Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship	2008
Physicochemical determinants of human renal clearance. Journal of medicinal chemistry, 2009, Aug-13, Volume: 52, Issue:15 Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight	2009
Searching for new cures for tuberculosis: design, synthesis, and biological evaluation of 2-methylbenzothiazoles. Journal of medicinal chemistry, 2009, Nov-12, Volume: 52, Issue:21 Topics: Antimalarials; Antitubercular Agents; Benzothiazoles; Drug Design; Isoxazoles; Models, Molecular; Mycobacterium tuberculosis; Phenylacetates; Stereoisomerism; Structure-Activity Relationship; Trypanocidal Agents	2009
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species. Chemical research in toxicology, 2010, Volume: 23, Issue:1 Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship	2010
Structure-activity relationship and mechanism of action studies of manzamine analogues for the control of neuroinflammation and cerebral infections. Journal of medicinal chemistry, 2010, Jan-14, Volume: 53, Issue:1 Topics: Animals; Anti-Infective Agents; Carbazoles; Cerebellar Diseases; Indole Alkaloids; Mice; Microbial Sensitivity Tests; Molecular Structure; Neurogenic Inflammation; Porifera; Stereoisomerism; Structure-Activity Relationship	2010
Synthesis, antimalarial and antitubercular activity of acetylenic chalcones. Bioorganic & medicinal chemistry letters, 2010, Feb-01, Volume: 20, Issue:3 Topics: Alkynes; Antimalarials; Antitubercular Agents; Chalcones; Mycobacterium tuberculosis; Plasmodium falciparum	2010
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination. Journal of medicinal chemistry, 2010, Feb-11, Volume: 53, Issue:3 Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations	2010
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species. Bioorganic & medicinal chemistry, 2010, Mar-15, Volume: 18, Issue:6 Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics	2010
Predicting phospholipidosis using machine learning. Molecular pharmaceutics, 2010, Oct-04, Volume: 7, Issue:5 Topics: Animals; Artificial Intelligence; Databases, Factual; Drug Discovery; Humans; Lipidoses; Models, Biological; Phospholipids; Support Vector Machine	2010
Interference with bile salt export pump function is a susceptibility factor for human liver injury in drug development. Toxicological sciences : an official journal of the Society of Toxicology, 2010, Volume: 118, Issue:2 Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Assay; Biological Transport; Cell Line; Cell Membrane; Chemical and Drug Induced Liver Injury; Cytoplasmic Vesicles; Drug Evaluation, Preclinical; Humans; Liver; Rats; Reproducibility of Results; Spodoptera; Transfection; Xenobiotics	2010
Synthesis and biological evaluation of benzimidazole-5-carbohydrazide derivatives as antimalarial, cytotoxic and antitubercular agents. Bioorganic & medicinal chemistry, 2011, Mar-15, Volume: 19, Issue:6 Topics: Animals; Antimalarials; Antitubercular Agents; Benzimidazoles; Cell Line, Tumor; Drug Resistance, Multiple; Hemin; Hemoglobins; Humans; Hydrazines; Hydrolysis; Mice; Plasmodium	2011
Novel thiolactone-isatin hybrids as potential antimalarial and antitubercular agents. Bioorganic & medicinal chemistry letters, 2011, Apr-01, Volume: 21, Issue:7 Topics: Animals; Antimalarials; Antitubercular Agents; Isatin; Lactones; Mycobacterium tuberculosis; Plasmodium falciparum; Structure-Activity Relationship	2011
FDA-approved drug labeling for the study of drug-induced liver injury. Drug discovery today, 2011, Volume: 16, Issue:15-16 Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration	2011
Classification of inhibitors of hepatic organic anion transporting polypeptides (OATPs): influence of protein expression on drug-drug interactions. Journal of medicinal chemistry, 2012, May-24, Volume: 55, Issue:10 Topics: Atorvastatin; Biological Transport; Drug Interactions; Estradiol; Estrone; HEK293 Cells; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; In Vitro Techniques; Least-Squares Analysis; Liver; Liver-Specific Organic Anion Transporter 1; Models, Molecular; Multivariate Analysis; Organic Anion Transporters; Organic Anion Transporters, Sodium-Independent; Protein Isoforms; Pyrroles; Solute Carrier Organic Anion Transporter Family Member 1B3; Structure-Activity Relationship; Transfection	2012
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds. Chemical research in toxicology, 2012, Oct-15, Volume: 25, Issue:10 Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding	2012
Synthesis and biological evaluation of a new class of 4-aminoquinoline-rhodanine hybrid as potent anti-infective agents. European journal of medicinal chemistry, 2013, Volume: 62 Topics: Aminoquinolines; Animals; Anti-Infective Agents; Chlorocebus aethiops; Dose-Response Relationship, Drug; Microbial Sensitivity Tests; Molecular Structure; Mycobacterium tuberculosis; Parasitic Sensitivity Tests; Plasmodium falciparum; Rhodanine; Structure-Activity Relationship; Vero Cells	2013
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development. Toxicological sciences : an official journal of the Society of Toxicology, 2013, Volume: 136, Issue:1 Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests	2013
Synthesis, characterization and pharmacological screening of some novel 5-imidazopyrazole incorporated polyhydroquinoline derivatives. European journal of medicinal chemistry, 2014, May-06, Volume: 78 Topics: Anti-Bacterial Agents; Antifungal Agents; Antimalarials; Bacteria; Dose-Response Relationship, Drug; Fungi; Microbial Sensitivity Tests; Molecular Structure; Parasitic Sensitivity Tests; Plasmodium falciparum; Polymers; Pyrazoles; Quinolines; Structure-Activity Relationship	2014
Design, synthesis and characterization of fluoro substituted novel pyrazolylpyrazolines scaffold and their pharmacological screening. European journal of medicinal chemistry, 2014, Sep-12, Volume: 84 Topics: Anti-Bacterial Agents; Antifungal Agents; Antimalarials; Bacteria; Dose-Response Relationship, Drug; Drug Design; Fungi; Microbial Sensitivity Tests; Molecular Structure; Parasitic Sensitivity Tests; Plasmodium falciparum; Pyrazoles; Structure-Activity Relationship	2014
Synthesis, antimalarial and antitubercular activities of meridianin derivatives. European journal of medicinal chemistry, 2015, Jun-15, Volume: 98 Topics: Animals; Antimalarials; Antitubercular Agents; Cell Line, Tumor; Humans; Indoles; Inhibitory Concentration 50; Plasmodium falciparum; Pyrimidines; Quantitative Structure-Activity Relationship; Sulfonamides	2015
Biologically Active Acetylenic Amino Alcohol and N-Hydroxylated 1,2,3,4-Tetrahydro-β-carboline Constituents of the New Zealand Ascidian Pseudodistoma opacum. Journal of natural products, 2016, Mar-25, Volume: 79, Issue:3 Topics: Alkynes; Animals; Antimalarials; Carbolines; Chloroquine; Drug Resistance, Bacterial; Escherichia coli; Inhibitory Concentration 50; Microbial Sensitivity Tests; Molecular Structure; Mycobacterium tuberculosis; New Zealand; Plasmodium falciparum; Staphylococcus aureus; Urochordata	2016
Natural product-based synthesis of novel anti-infective isothiocyanate- and isoselenocyanate-functionalized amphilectane diterpenes. Bioorganic & medicinal chemistry letters, 2016, Feb-01, Volume: 26, Issue:3 Topics: Animals; Anti-Infective Agents; Biological Products; Cyanates; Diterpenes; Inhibitory Concentration 50; Isothiocyanates; Mycobacterium tuberculosis; Plasmodium falciparum; Porifera; Selenium Compounds	2016
Novel morpholinoquinoline nucleus clubbed with pyrazoline scaffolds: Synthesis, antibacterial, antitubercular and antimalarial activities. European journal of medicinal chemistry, 2016, Apr-13, Volume: 112 Topics: Anti-Infective Agents; Antimalarials; Antitubercular Agents; Bacteria; Bacterial Infections; Fungi; Humans; Malaria, Falciparum; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Mycoses; Plasmodium falciparum; Pyrazoles; Quinolines; Structure-Activity Relationship; Tuberculosis	2016
Development of a cell viability assay to assess drug metabolite structure-toxicity relationships. Bioorganic & medicinal chemistry letters, 2016, 08-15, Volume: 26, Issue:16 Topics: Adenosine Triphosphate; Benzbromarone; Cell Line; Cell Survival; Chromans; Cytochrome P-450 CYP2C9; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Humans; Pharmaceutical Preparations; Thiazolidinediones; Troglitazone	2016
Synthesis, identification and in vitro biological evaluation of some novel quinoline incorporated 1,3-thiazinan-4-one derivatives. Bioorganic & medicinal chemistry letters, 2017, 02-01, Volume: 27, Issue:3 Topics: Anti-Bacterial Agents; Antimalarials; Antitubercular Agents; Clostridium tetani; Gram-Negative Bacteria; Magnetic Resonance Spectroscopy; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Plasmodium falciparum; Quinolines; Spectroscopy, Fourier Transform Infrared; Structure-Activity Relationship; Thiazines	2017
Broad activity of diphenyleneiodonium analogues against Mycobacterium tuberculosis, malaria parasites and bacterial pathogens. European journal of medicinal chemistry, 2018, Mar-25, Volume: 148 Topics: Animals; Bacteria; Community-Acquired Infections; Cross Infection; Gram-Negative Bacteria; Gram-Positive Bacteria; Malaria; Mycobacterium tuberculosis; Onium Compounds; Structure-Activity Relationship	2018
Synthesis and biological evaluation of 2-chloro-3-[(thiazol-2-yl)amino]-1,4-naphthoquinones. Bioorganic & medicinal chemistry letters, 2019, 07-01, Volume: 29, Issue:13 Topics: Humans; Molecular Structure; Naphthoquinones; Structure-Activity Relationship	2019
Bioisosteric ferrocenyl aminoquinoline-benzimidazole hybrids: Antimicrobial evaluation and mechanistic insights. European journal of medicinal chemistry, 2019, Oct-15, Volume: 180 Topics: Animals; Anti-Bacterial Agents; Antimalarials; Benzimidazoles; Disease Models, Animal; Dose-Response Relationship, Drug; Ferrous Compounds; Malaria; Mice; Molecular Structure; Mycobacterium tuberculosis; Parasitic Sensitivity Tests; Plasmodium falciparum; Quinolines; Structure-Activity Relationship	2019
Synthesis and biological evaluation of bis-N Bioorganic & medicinal chemistry letters, 2020, 03-01, Volume: 30, Issue:5 Topics: Antifungal Agents; Antitubercular Agents; Catalytic Domain; Coumarins; HeLa Cells; HIV Integrase; HIV Integrase Inhibitors; HIV-1; Humans; Hydrazines; Microbial Sensitivity Tests; Molecular Docking Simulation; Mycobacterium tuberculosis; Protein Binding; Trypanocidal Agents; Trypanosoma brucei brucei	2020
Synthesis and efficacy of pyrvinium-inspired analogs against tuberculosis and malaria pathogens. Bioorganic & medicinal chemistry letters, 2020, 04-15, Volume: 30, Issue:8 Topics: Antimalarials; Antitubercular Agents; Dose-Response Relationship, Drug; Malaria, Falciparum; Microbial Sensitivity Tests; Molecular Structure; Mycobacterium tuberculosis; Parasitic Sensitivity Tests; Plasmodium falciparum; Pyrvinium Compounds; Structure-Activity Relationship; Tuberculosis	2020
Antimicrobial and Cytotoxic Angucyclic Quinones from Journal of natural products, 2021, 11-26, Volume: 84, Issue:11 Topics: Actinomadura; Anti-Infective Agents; Antineoplastic Agents; Cell Line, Tumor; Humans; Magnetic Resonance Spectroscopy; Mycobacterium tuberculosis; Plasmodium falciparum; Quinolones	2021
Treatment of Hansen's disease. Cutis, 1976, Volume: 18, Issue:1 Topics: Chloroquine; Clofazimine; Dapsone; Drug Resistance, Microbial; Erythema Nodosum; Humans; Leprosy; Prednisone; Rifampin; Thalidomide	1976
[Changes in the functional activity of macrophages, their morphology and metabolism under the influence of several biologically active substances]. Tsitologiia, 1975, Volume: 17, Issue:2 Topics: Ascorbic Acid; Carbon Radioisotopes; Cathepsins; Chloramphenicol; Chloroquine; Creatine Kinase; Culture Techniques; Cycloheximide; Dactinomycin; Lipopolysaccharides; Lysine; Macrophages; Orotic Acid; Peritoneum; Phagocytosis; Protein Biosynthesis; Puromycin; Rifampin; RNA; Tetracycline; Uridine	1975
Phagolysosomal alkalinization and the bactericidal effect of antibiotics: the Coxiella burnetii paradigm. The Journal of infectious diseases, 1992, Volume: 166, Issue:5 Topics: Amantadine; Ammonium Chloride; Animals; Anti-Bacterial Agents; Cell Line; Chloroquine; Coxiella burnetii; Doxycycline; Hydrogen-Ion Concentration; Lysosomes; Macrophages; Mice; Pefloxacin; Phagocytosis; Rifampin	1992
The effect of metabolic inhibitors and hydroxylamine on the immune response in mice to mycobacterial ribonucleic acid vaccines. Journal of immunology (Baltimore, Md. : 1950), 1974, Volume: 112, Issue:1 Topics: Animals; Antibody Formation; Antimetabolites; Bacterial Vaccines; Chloramphenicol; Chloroquine; Cycloheximide; Dactinomycin; Ethidium; Flavins; Floxuridine; Hemagglutination Tests; Hydroxylamines; Male; Mice; Mycobacterium tuberculosis; Rifampin; RNA, Bacterial; Streptomycin; Vaccination	1974
[Changes in the immunologic response to bacteriophage T2 due to the transcription inhibitors actinomycin D, olivomycin, rifomycin and chloroquine]. Zhurnal mikrobiologii, epidemiologii i immunobiologii, 1972, Volume: 49, Issue:4 Topics: Animals; Antibody Formation; Antigens, Viral; Chloroquine; Coliphages; Dactinomycin; Immunization; Mice; Oligomycins; Rifampin	1972
Antimalarial effects of rifampin in Plasmodium vivax malaria. Antimicrobial agents and chemotherapy, 1994, Volume: 38, Issue:3 Topics: Adolescent; Adult; Animals; Chloroquine; Drug Therapy, Combination; Humans; Malaria, Vivax; Male; Middle Aged; Pilot Projects; Plasmodium vivax; Primaquine; Rifampin	1994
Effect of chloroquine on phagolysosomal fusion in cultured guinea pig alveolar macrophages: implications in drug delivery. AAPS pharmSci, 2000, Volume: 2, Issue:4 Topics: Animals; Antibiotics, Antitubercular; Cells, Cultured; Chloroquine; Dextrans; Drug Synergism; Fluorescent Dyes; Guinea Pigs; Lysosomes; Macrophages, Alveolar; Microscopy, Fluorescence; Microspheres; Phagosomes; Rhodamines; Rifampin	2000
Rifampicin antagonizes the effect of choloroquine on chloroquine-resistant Plasmodium berghei in mice. Japanese journal of infectious diseases, 2004, Volume: 57, Issue:5 Topics: Animals; Antimalarials; Chloroquine; Drug Resistance; Drug Therapy, Combination; Malaria; Mice; Parasitemia; Plasmodium berghei; Rifampin	2004
A man with a blistering eruption and tuberculosis. BMJ (Clinical research ed.), 2012, Jan-06, Volume: 344 Topics: Antimalarials; Antitubercular Agents; Chloroquine; Diagnosis, Differential; Drug Therapy, Combination; Feces; Hepatitis C; Humans; Iron Overload; Male; Middle Aged; Phlebotomy; Photosensitivity Disorders; Porphyria Cutanea Tarda; Porphyrins; Rifampin; Risk Factors; Skin Diseases, Vesiculobullous; Tuberculosis, Pulmonary	2012
Rifampicin inhibits rotenone-induced microglial inflammation via enhancement of autophagy. Neurotoxicology, 2017, Volume: 63 Topics: Analysis of Variance; Antirheumatic Agents; Autophagy; Cell Line, Tumor; Chloroquine; Coculture Techniques; Humans; Insecticides; Interleukin-1beta; Interleukin-6; Membrane Potential, Mitochondrial; Microglia; Microscopy, Electron, Transmission; Mitochondria; Neuroblastoma; Neuroprotective Agents; Reactive Oxygen Species; Rifampin; Rotenone	2017
Unusual association of COVID-19, pulmonary tuberculosis and human immunodeficiency virus, having progressed favorably under treatment with chloroquine and rifampin. The Pan African medical journal, 2020, Volume: 35, Issue:Suppl 2 Topics: Adult; Antimalarials; Antiviral Agents; Chloroquine; COVID-19; COVID-19 Drug Treatment; Diagnosis, Differential; Drug Therapy, Combination; Female; HIV Infections; HIV-1; Humans; Rifampin; SARS-CoV-2; Tomography, X-Ray Computed; Tuberculosis, Pulmonary	2020